ENHANCED BIMATOPROST OPHTHALMIC SOLUTION
A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hyperten...
Saved in:
Main Authors | , , , , |
---|---|
Format | Patent |
Language | English |
Published |
01.09.2016
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein. |
---|---|
AbstractList | A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous liquid which is formulated for ophthalmic administration is disclosed herein. A method which is useful in treating glaucoma or ocular hypertension related thereto is also disclosed herein. |
Author | Schiffman Rhett M Jordan R. Scott Chang Chin-Ming Chang-Lin Joan-En Chang James N |
Author_xml | – fullname: Chang-Lin Joan-En – fullname: Chang James N – fullname: Jordan R. Scott – fullname: Chang Chin-Ming – fullname: Schiffman Rhett M |
BookMark | eNrjYmDJy89L5WTQcPXzcPRzdnVRcPL0dQzxDwjyDw5R8A_wCPFw9PH1dFYI9vcJDfH09-NhYE1LzClO5YXS3AzKbq4hzh66qQX58anFBYnJqXmpJfGhwUYGhmZGpgZGRqaOhsbEqQIApaonAw |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
ExternalDocumentID | US2016250225A1 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_US2016250225A13 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 14:01:54 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_US2016250225A13 |
Notes | Application Number: US201514876611 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160901&DB=EPODOC&CC=US&NR=2016250225A1 |
ParticipantIDs | epo_espacenet_US2016250225A1 |
PublicationCentury | 2000 |
PublicationDate | 20160901 |
PublicationDateYYYYMMDD | 2016-09-01 |
PublicationDate_xml | – month: 09 year: 2016 text: 20160901 day: 01 |
PublicationDecade | 2010 |
PublicationYear | 2016 |
RelatedCompanies | Allergan, Inc |
RelatedCompanies_xml | – name: Allergan, Inc |
Score | 3.0529633 |
Snippet | A composition comprising from 0.005% to 0.02% bimatoprost by weight and from 100 ppm to 250 ppm benzalkonium chloride, wherein said composition is an aqueous... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
Title | ENHANCED BIMATOPROST OPHTHALMIC SOLUTION |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20160901&DB=EPODOC&locale=&CC=US&NR=2016250225A1 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1bS8MwFD6MKeqbTsXLlIJSfCn2Etv6UKRXqqxNWVvZ21i6BgSZw1X8-57UTve0tyQHTpJDTr58uZwA3JLqUbfnjCu4GK0VojGizBjXFIRiXTNqYmpMEMUkNeOSvEweJj14X7-FaeOEfrfBEdGjKvT3pp2vl_-bWEF7t3J1z96w6OMpKpxA7tixZqqIb3LgOWFGA-rLvu-UuZyOWxmiPY5eF7nSDi6kLeEP4asn3qUsN0ElOoTdDPUtmiPo1YsB7Pvrv9cGsJd0R96Y7LxvdQx3YRqLv2QCyXtO3IJmY5oXEs3iInZHaE4pp6NSbDmdwE0UFn6sYJXTvx5Oy3yzfcYp9JH712cgGTazLE4qXWU64Spn5gxtqNkWRxpmz_g5DLdputguvoQDkf29MjWEfvP5VV8hxjbsujXND01CeoA |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LS8NAEB5KFetNq-KjakAJXoJ5rEk8BMmTVPOiSaS3kk2zIEgtNuLfdxJT7am3ZQf2Mezst9_uzCzALSkfZX1OmYCH0UogEiVCQZkkIBTLklIRVaINUQwj1c_J8_Rh2oP3dSxMmyf0u02OiBZVor3X7X69_L_EclrfytU9fcOqjycvMxy-Y8eSKiK-8Y5luEnsxDZv20ae8tGklSHa4-o1kSvt4CFba-zBfbWauJTlJqh4B7CbYHuL-hB61WIIA3v999oQ9sLuyRuLnfWtjuDOjfzmLxmHs8ahmcXJJE4zLk78zDcDVCeXxkHeXDkdw43nZrYvYJezvxnO8nRzfMoJ9JH7V6fAKTrVNEZKWaQyYSKjaoE6lHSNIQ3TC3YGo20tnW8XX8PAz8JgFoyjlwvYb0S_7lMj6NefX9Ul4m1Nr1o1_QA2-X1z |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=ENHANCED+BIMATOPROST+OPHTHALMIC+SOLUTION&rft.inventor=Chang-Lin+Joan-En&rft.inventor=Chang+James+N&rft.inventor=Jordan+R.+Scott&rft.inventor=Chang+Chin-Ming&rft.inventor=Schiffman+Rhett+M&rft.date=2016-09-01&rft.externalDBID=A1&rft.externalDocID=US2016250225A1 |